Multi-phase Oral Composition for Controlled Active Agent Delivery

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current dental products face limitations in delivering active agents effectively due to increased side effects from high concentrations and regulatory restrictions on bleaching agents, necessitating a more efficient and safer method for oral care.

Innovation Solution

A multi-phase oral composition comprising an aqueous phase with a hydrophobic phase, where the hydrophobic phase is in predominant proportion, allowing for the delivery of active agents at low concentrations with enhanced efficacy and reduced side effects, using a water-in-oil emulsion that can be applied via strips or trays, and is designed to minimize tooth sensitivity.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If the level of active agent in the composition is increased to improve efficacy, then the therapeutic effect is enhanced, but side effects increase and regulatory compliance becomes difficult

Engineering Contradiction:
ImproveefficacyVSAvoidside effects
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The composition is divided into two distinct phases: an aqueous phase containing the active agent and a hydrophobic phase. This segmentation allows the active agent to be delivered in a controlled manner through the aqueous phase while the hydrophobic phase provides a stable matrix that prevents excessive release, thereby reducing side effects while maintaining efficacy.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The hydrophobic phase acts as an intermediary between the active agent and the oral environment. It controls the release of the active agent from the aqueous phase, ensuring that effective concentrations are delivered to the teeth while preventing excessive amounts that would cause side effects or regulatory issues.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Reliability

If the level of active agent in the composition is increased to improve efficacy, then the therapeutic effect is enhanced, but regulatory compliance is compromised

Engineering Contradiction:
ImproveefficacyVSAvoidregulatory compliance
Core Design Contradiction:
ReliabilityVSAdaptability or versatility

Solution Approach 1:

By segmenting the composition into aqueous and hydrophobic phases, the patent enables compliance with regulatory limits on active agent concentration in the overall composition while still achieving effective delivery to the teeth through the controlled release mechanism of the aqueous phase.

Inventive Principle:
Principle #1Segmentation

3Ease of manufacture

If a single-phase composition is used for simplicity, then the formulation is easier, but the delivery efficacy is reduced

Engineering Contradiction:
Improveformulation simplicityVSAvoiddelivery efficacy
Core Design Contradiction:
Ease of manufactureVSReliability

Solution Approach 1:

The patent employs a composite formulation combining an aqueous phase with a hydrophobic phase. This composite structure enhances the delivery efficacy by providing both the active agent carrier (aqueous phase) and a stable release matrix (hydrophobic phase), while the formulation process remains straightforward using standard emulsification techniques.

Inventive Principle:
Principle #40Composite materials

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The multi-phase composition effectively delivers active agents at low concentrations, reducing side effects and compliance with regulatory limits, while maintaining high bleaching efficacy and stability, as demonstrated by the composition's ability to achieve significant whitening results with minimal active agent exposure.

Implementation Method 1

The present invention relates to multi-phase oral compositions for delivering active agents... comprising an aqueous phase... and a hydrophobic phase... wherein the hydrophobic phase may be in predominant proportion relative to the aqueous phase

Methodology Applied
Scientific EffectEmulsion: Emulsion

Data Source

PatentUS20220040061A1Multi-phase oral composition for delivering oral care active agents
Publication Date: 2022.02.10 PROCTER & GAMBLE CO
  • US20220040061A1 patent drawing
  • US20220040061A1 patent drawing
  • US20220040061A1 patent drawing

AI summary

A multi-phase oral composition for delivering active agents.